MAP3K13 anticorps (AA 801-900) (Biotin)

N° du produit ABIN5557388

Détail du produit anti-MAP3K13 anticorps (Biotin)

Antigène: MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))

Épitope: AA 801-900

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MAP3K13 est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Réactivité croisée: Humain, Souris

Homologie: Cow

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human MAP3K13

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur MAP3K13

Antigène: MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))

Autre désignation: MAP3K13 (MAP3K13 Produits)

Synonymes: anticorps LZK, anticorps MEKK13, anticorps MLK, anticorps C130026N12Rik, anticorps lzk, anticorps map3k13, anticorps map3k13a, anticorps mekk13, anticorps map3k13-a, anticorps map3k13-b, anticorps map3k13b, anticorps mitogen-activated protein kinase kinase kinase 13, anticorps mitogen-activated protein kinase kinase kinase 13 L homeolog, anticorps mitogen-activated protein kinase kinase kinase 13 S homeolog, anticorps MAP3K13, anticorps Map3k13, anticorps map3k13.L, anticorps map3k13, anticorps map3k13.S

Sujet:

Synonyms: Mitogen-activated protein kinase kinase kinase 13, MAP3K13, Leucine zipper-bearing kinase, Mixed lineage kinase, MLK, LZK

Background: Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.

ID gène: 9175

UniProt: O43283

Pathways: Signaling Events mediated by VEGFR1 and VEGFR2